SCHEMBL6702376

SCHEMBL6702376

CC(=O)Oc1cc(OC(C)=O)c2c(c1)OC(c1ccc(OC(C)=O)c(OC(C)=O)c1)C(O)C2

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.77
MAPK1 P28482 3/20 0.77
ALDH1A1 P00352 3/20 0.77
SMN1; SMN2 Q16637 2/20 0.77
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
ABCB1 P08183 3/20 0.55
MAPT P10636 3/20 0.55
SYNJ2 O15056 2/20 0.51
STING1 Q86WV6 3/20 0.48
BACE1 P56817 4/20 0.44
KDM4E B2RXH2 3/20 0.44
GAA P10253 2/20 0.44
PKM P14618 2/20 0.44
HSD17B10 Q99714 2/20 0.44
APEX1 P27695 2/20 0.44
RECQL P46063 2/20 0.44
APP P05067 1/20 0.44
ALPL P05186 1/20 0.44
AMY1A P0DUB6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14701484 1.00 CYP3A4 (0.77) CYP3A4MAPK1ALDH1A1SMN1; SMN2MEN1
(+/-)-Pentaacetylcatechin SCHEMBL719420 0.87 ALDH1A1 (1.00) CYP3A4MAPK1ALDH1A1SMN1; SMN2MEN1
Epicatechin Pentaacetate SCHEMBL14691288 0.87 ALDH1A1 (1.00) CYP3A4MAPK1ALDH1A1SMN1; SMN2MEN1
Catechin Pentaacetate SCHEMBL719419 0.87 ALDH1A1 (1.00) CYP3A4MAPK1ALDH1A1SMN1; SMN2MEN1
(+/-)-Pentaacetylcatechin SCHEMBL14701425 0.87 ALDH1A1 (1.00) CYP3A4MAPK1ALDH1A1SMN1; SMN2MEN1
SCHEMBL14701451 0.84 BACE1 (0.65) CYP3A4MAPK1ALDH1A1SMN1; SMN2MEN1
SCHEMBL29682334 0.84 BACE1 (0.65) CYP3A4MAPK1ALDH1A1SMN1; SMN2MEN1
SCHEMBL29105259 0.84 BACE1 (0.65) CYP3A4MAPK1ALDH1A1SMN1; SMN2MEN1
SCHEMBL15653779 0.84 MEN1 (0.78) CYP3A4MAPK1ALDH1A1SMN1; SMN2MEN1
SCHEMBL16150664 0.83 CYP3A4 (0.55) CYP3A4MAPK1ALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040266699-A1 Flavonoid compounds capable of modifying the dynamic and/or physical state of biological membranes and to stimulate the endogenous synthesis of stress proteins in eukaryotic cells, relative synthesis and their use BRANE TECH S.R.L. (IT) 2004-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040266699-A1 Flavonoid compounds capable of modifying the dynamic and/or physical state of biological membranes and to stimulate the endogenous synthesis of stress proteins in eukaryotic cells, relative synthesis and their use TFEB, HSF1, JUN CYP3A4 1736/4885MAPK1 192/4885ALDH1A1 3589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.